Skip to content

Laparoscopic Prostatectomy for Chronic Prostatitis

Laparoscopic Prostatectomy for Chronic Prostatitis

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00775515
Enrollment
100
Registered
2008-10-20
Start date
2008-10-31
Completion date
2015-10-31
Last updated
2011-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Prostatitis

Keywords

chronic, prostatitis, prostate, pain, pelvic, pelvis, inflamation

Brief summary

Prostatitis is an inflammation of the prostate, an pelvic organ of men. Prostatitis can cause great discomfort which varies but can include pelvic pain, pelvic pressure, a vague sense of discomfort, a feeling of malaise and fatigue, fever, burning on urination, pain on reaching orgasm, and bleeding. In many men the symptoms of prostatitis can be chronic. It is estimated that in the United States chronic prostatitis is responsible for as many as two million doctor visits a year. The disease can be ruinous, interfering with work, intimacy, and other things. The causes of chronic prostatitis are not understood. The treatments commonly used, including antibiotics and prostate massage, work poorly. We now have evidence that laparoscopic prostatectomy can eliminate the misery of chronic prostatitis. This trial aims to quantify and better characterize the effect of laparoscopic prostatectomy on the symptoms of chronic prostatitis.

Interventions

PROCEDURElaparoscopic prostatectomy

laparoscopic prostatectomy

Sponsors

The Krongrad Institute
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
30 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 30 and greater * NIH-CPSI score of 25 and higher * Symptom duration of at least one year * Failed treatment with antibiotics and/or other medications

Exclusion criteria

* Inability to tolerate Anesthesia * Inability to speak any English

Design outcomes

Primary

MeasureTime frame
NHI CPSI (chronic prostatitis symptom index)3 years

Countries

United States

Contacts

Primary ContactArnon Krongrad, MD
ak@laprp.com305-936-0474
Backup ContactRuth Krongrad, BSC
ruth@laprp.com305-936-0474

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026